Mucuna para Mejora de síntomas motores en Parkinson

Mucuna pruriens — 10 estudios científicos revisados

Moderate

¿Sirve Mucuna para mejora de síntomas motores en parkinson?

El extracto de las semillas proporciona L-dopa natural, que atraviesa la barrera hematoencefálica para convertirse en dopamina, compensando la deficiencia de este neurotransmisor en el cerebro.

Compuestos activos involucrados: Alcaloides, Flavonoides, Saponinas, Terpenos

Evidencia Científica

Los siguientes estudios han investigado la relación entre Mucuna y mejora de síntomas motores en parkinson:

Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases.

The medicinal plant Mucuna pruriens (Fabaceae) is widely known for its anti-oxidative and anti-inflammatory properties. It is a well-established drug in Ayurveda and has been widely used for the treatment of neurological disorders and male infertility for ages. The seeds of the plant have potent medicinal value and its extract has been tested in different models of neurodegenerative diseases, especially Parkinson's disease (PD). Apart from PD, Mucuna pruriens is now being studied in models of other nervous systems disorders such as Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS)

PubMed: 35380400

Mucuna pruriens to treat Parkinson's disease in low-income countries: Recommendations and practical guidelines from the farmer to clinical trials. Paving the way for future use in clinical practice.

Parkinson's disease (PD) is a progressive and disabling neurodegenerative disease that rapidly worsens and results in premature mortality if left untreated. Although levodopa is the gold standard treatment for PD globally, its accessibility and affordability are severely limited in low- and middle-income countries worldwide. In this scenario, Mucuna pruriens (MP), a leguminous plant growing wild in tropical regions, emerges as a potential alternative or adjunct to levodopa-based medications due to its cost-effectiveness and global natural availability. Recent studies have demonstrated that MP

PubMed: 38797572

The Magic Velvet Bean of Mucuna pruriens.

Mucuna pruriens (Fabaceae) is an established herbal drug used for the management of male infertility, nervous disorders, and also as an aphrodisiac. It has been shown that its seeds are potentially of substantial medicinal importance. The ancient Indian medical system, Ayurveda, traditionally used M. pruriens, even to treat such things as Parkinson's disease. M.

PubMed: 24716148

L-dopa, a dopaminergic agonist, is the gold standard for the treatment of Parkinson's disease. However, due to the long-term toxicity and adverse effects of using L-dopa as the first-line therapy for Parkinson's disease, a search for alternative medications is an important current challenge. Traditional Ayurvedic medicine has suggested the use of

PubMed: 35630617

Antineoplastic Effects of Mucuna pruriens Against Human Colorectal Adenocarcinoma.

Mucuna pruriens (MP) which is commonly known as "Velvet Bean" is an underutilized legume traditionally used to treat Parkinson's disease and male fertility issues. Extracts of MP have also been identified for their antidiabetic, antioxidant, and antineoplastic effects. Commonly, the antioxidant and anticancer properties of a drug are linked together as antioxidants scavenge free radicals and prevent the cellular DNA damage which could result in cancer development. In this investigation, comparative assessment of the anticancer and antioxidant potentials of methanolic seed extracts from two com

PubMed: 37395947

Seguridad y Precauciones

El uso de Mucuna pruriens conlleva riesgos significativos debido a su alto contenido de L-dopa, un precursor directo de la dopamina. En el contexto de embarazo y lactancia, el uso de esta planta está estrictamente contraindicado. La estimulación dopaminérgica puede interferir con el desarrollo neurológico fetal y no existen estudios que garanticen la ausencia de efectos teratogénicos (malformaciones) o alteraciones en el neurodesarrollo del lactante a través de la leche materna. En niños menores de 12 años, su administración debe evitarse por completo, ya que el sistema nervioso en desarrollo es extremadamente sensible a las fluctuaciones de neurotransmisores, lo que podría derivar en trastornos del crecimiento, alteraciones conductuales o desequilibrios hormonales severos. Respecto a las interacciones farmacológicas, Mucuna pruriens presenta riesgos críticos. Al interactuar con fármacos antihipertensivos, especialmente aquellos que afectan el sistema nervioso central, puede causar fluctuaciones imprevistas en la presión arterial.

Ver perfil de seguridad completo de Mucuna →

Perfil completo: Ver todos los usos y evidencia de Mucuna →